Capsular Switching in Group B Streptococcus CC17 Hypervirulent Clone: A Future Challenge for Polysaccharide Vaccine Development

Samuel Bellais, Anne Six, Agnès Fouet, M. Longo, Nicolas Dmytruk, Philippe Glaser, Patrick Trieu‐Cuot, Claire Poyart

The Journal of Infectious Diseases · 2012 · 142 citations · 40 references

DOIFull text

Open access

Abstract

This work shows that GBS CC17 hypervirulent strains have switched one of their main vaccine targets. Thus, continued surveillance of GBS population remains of the utmost importance during clinical trials of conjugate GBS vaccines.

References

40